Founded by a general surgeon, The Xenoscope™ took wings to revolutionize the current laparoscopy market system to overcome barriers of high capital cost and clinically improve cross-contamination and efficiency of procedures. The goal is to unlock the benefits of the novel laparoscopic technology to millions of patients worldwide.

Xenocor Inc. at a glance:

• Xenoscope™ technology has been FDA cleared and CE marked
• Granted breakthrough technology agreement with Premier Inc.
• Secured investments from prominent bodies, ex; Trudell Medical Group, Impact Ventures, Mountain Pacific Venture Fund
• Medtech Innovator’s Top 50 Medtech Startups for Annual Showcase and Accelerator
• Lead by board of directors with extensive past experiences and knowledge in the medical devices’ industry, ex; Medtronic/Covidien/Valleylab/Ethicon/Depuy Synthes